Several case studies reported patients with intellectual disability, cerebellar hypoplasia and/or cortical hypoplasia, epilepsy as well as gait abnormalities, muscle weakness, decreased skeletal muscle fiber diameter with hypoglycosylation of alpha-dystroglycan and reduced nerve conductance. Here, DAG1 is linked to epilepsy.